More than 440 healthcare professionals in Nova Scotia have adopted artificial intelligence technology to document patient interactions since the launch of a pilot program in June, as reported by the Department of Health and Wellness.
Canada Health Infoway initiated the program, offering free one-year licenses to primary care clinicians nationwide for AI documentation tools. These tools enable healthcare providers to capture patient conversations and generate real-time summaries for both medical professionals and patients.
Nova Scotia has 500 funded licenses available for the program. Shelly McNeil, president of Doctors Nova Scotia, expressed strong support for innovative technologies like AI scribe, emphasizing their potential to improve patient care and assist doctors in achieving a better work-life balance.
Dr. Ajantha Jayabarathan, a family physician in Halifax, noted that utilizing Mika AI scribe significantly reduces the time spent on post-visit documentation, allowing her to efficiently move on to other tasks. Mika AI scribe is the sole AI scribe approved for use by Nova Scotia Health clinics and healthcare professionals in the province.
Jayabarathan praised the accuracy of the AI tool’s transcriptions, although manual editing is still necessary before incorporating the notes into electronic medical records. Clinicians in Nova Scotia are required to review and edit the outputs of the AI scribe to ensure accuracy, with patients retaining the right to revoke consent at any time.
Infoway’s executive vice-president of connected care, Abhi Kalra, highlighted positive initial survey results, stating that no concerns have been raised regarding the AI scribe technology. The nine AI scribe technology vendors participating in the national program were selected based on criteria such as data security and privacy practices and alignment with national standards.
According to Frank Rudzicz, a computer science professor at Dalhousie University with expertise in AI scribe technology, the technology is considered “relatively safe” for converting conversations into transcripts. However, potential challenges may arise if the tool is involved in decision-making processes.
Nova Scotia Health’s program policy recommends the removal of AI scribe notes from the tool within seven days to protect patient privacy. Rudzicz emphasized the importance of patients being informed about the data process and location to make informed consent decisions.
Rudzicz urged for patient involvement in the conversation surrounding AI technology to ensure transparency and collective efforts in advancing healthcare practices.
For more details, visit the source link.